Cilostazol is a selective phosphodiesterase-3 inhibitor with antiplatelet and vasodilatory properties, used for symptomatic relief of intermittent claudication in peripheral arterial disease. Simson Pharma's Cilostazol reference standard and impurities support compendial testing for this peripherally acting vasodilator.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cilostazol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.